Treatable Intellectual Disability

Maple Syrup Urine Disease (Variant)

DIAGNOSIS

Gene
BCKDHA / BCKDHB/ DBT (AR)

Diagnostic Test
Plasma Amino Acids

Stacks Image 320

SIGNS & SYMPTOMS

Neurological
Encephalopathic crisis, ataxia, psychiatric disturbances, dystonia, areflexia

Non-Neurological
Urine maple syrup odor

Stacks Image 321

THERAPY

Treatment
Amino Acids, Avoid Fasting

Level of Evidence /
Clinical Care
4 / Standard of Care

Treatment Effect
Stabilizes clinical deterioration; prevents metabolic decompensation; improves behaviour



Stacks Image 322

THERAPY

Treatment
Liver Transplantation

Level of Evidence /
Clinical Care
4 / Individual Basis

Treatment Effect
Improves psychomotor development/IQ; prevents metabolic decompensation


Stacks Image 323
Maple Syrup Urine Disease (Variant)

Maple Syrup Urine Disease (Variant)

Maple syrup urine disease (MSUD) is caused by branched-chain alpha-ketoacid dehydrogenase deficiency which affects the degradation of branched-chain amino acids leucine, isoleucine, and valine. The early onset classic form manifests after birth by lethargy, poor feeding and neurological signs of intoxication. Late onset forms manifest usually within the first year of life with irritability and extrapyramidal movements which untreated may progress to lethargy and ketoacidotic coma. Repeated episodes result in progressive brain atrophy and intellectual disability. in some patients the initial presentation is quite unspecific including hypotonia, failure to thrive and developmental delay. Thiamine-responsive MSUD is a very rare form characterized by improvement of the biochemical profile with thiamine therapy. (Source: Orphanet)

No information available from this source.

This disease is not (yet) listed on their website.